Filing Flows

Filing Flows › Comparisons › RARE vs LQDA

Ultragenyx Pharmaceutical vs Liquidia: RARE and LQDA compared

Ultragenyx Pharmaceutical is the larger company: $173M of revenue in its latest quarter (Q3 2026) against $172M for Liquidia (Q2 2026). Liquidia is growing faster (19× against +8% a year earlier). Liquidia is more profitable, with an operating margin of 49.8% against -63.6%.

Ultragenyx Pharmaceutical vs Liquidia, latest quarterUltragenyx Pharmaceutical vs Liquidia, latest quarterUltragenyx Pharmaceutical (RARE)Liquidia (LQDA)Revenue$173M$172MRevenue growth, Y/Y+8%19×Operating margin-63.6%49.8%Net margin-68.2%43.5%

Where the money goes: RARE and LQDA

Ultragenyx Pharmaceutical (RARE) · Q3 2026

Ultragenyx Pharmaceutical, Q3 2026: revenue $173M (+8% year over year), operating margin -63.6%, net loss $118M, operating cash flow −$43.0M. The chart follows the revenue to costs, profit and cash.

Liquidia (LQDA) · Q2 2026

Liquidia, Q2 2026: revenue $172M (19× year over year), operating margin 49.8%, net earnings $74.7M, operating cash flow $80.2M. The chart follows the revenue to costs, profit and cash.

Ultragenyx Pharmaceutical revenue by segment, Q3 2026Ultragenyx Pharmaceutical revenue by segment, Q3 2026Product$105MRoyalty$68.0M
Liquidia revenue by segment, Q2 2026Liquidia revenue by segment, Q2 2026Product sales, net$170MService revenue, net$1.3M
Ultragenyx Pharmaceutical (RARE)Liquidia (LQDA)
Latest quarterQ3 2026Q2 2026
Revenue$173M$172M
Revenue growth, Y/Y+8%19×
Operating margin-63.6%49.8%
Net earnings−$118M$74.7M
Net margin-68.2%43.5%
Operating cash flow−$43.0M$80.2M
Free cash flow—$69.0M
Market value$1.6B—
Analysts’ mean target$25.40—

Where the revenue comes from

Ultragenyx Pharmaceutical

Liquidia

Questions

Which is bigger, Ultragenyx Pharmaceutical or Liquidia?

Ultragenyx Pharmaceutical is the larger company: $173M of revenue in its latest quarter (Q3 2026) against $172M for Liquidia (Q2 2026).

Is Ultragenyx Pharmaceutical or Liquidia growing faster?

Liquidia is growing faster (19× against +8% a year earlier).

Which is more profitable, Ultragenyx Pharmaceutical or Liquidia?

Liquidia is more profitable, with an operating margin of 49.8% against -63.6%.

More: Ultragenyx Pharmaceutical earnings · how Ultragenyx Pharmaceutical makes money · Liquidia earnings · how Liquidia makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.